Anthropic’s IPO Has a Seller Door and an Employee Door

Anthropic's proposed IPO can produce cash for the company and cash for existing shareholders on the same closing day. Those are different transactions. The company plans to issue new Class A stock; selling stockholders plan to sell Class A stock they already own. The preliminary prospectus identifies seven co-founders as the proposed sellers and says Anthropic will receive none of their sale proceeds. It has not filled in the offer price, either share count, or the amounts each founder would sell.^S1

There is a second separation after trading starts. Some non-founder employees may gain a limited transfer right on the first trading day, while founders and large holders have longer staged restrictions on shares they retain. The pitch deck can call this “IPO liquidity.” Employees will want the date, percentage, and registration path before calling it cash.

The SpaceX IPO lockup story showed a completed, primary-only offering followed by staged releases. Anthropic's filing adds a sale by existing holders at the offering itself. Its separate employee path means the first day of trading could matter to more than the buyers of IPO shares. The five-class control map explains why receiving IPO cash and retaining voting power are separate questions here. This article follows the terms in Anthropic's S-1 as filed on October 26, 2026. The registration statement is preliminary; the proposed offering and schedules may change before pricing.^S1

Start with one public buyer paying the eventual offer price for one Class A share. The destination of the money depends on who supplies that share. If Anthropic issues it, the company receives the price less its underwriting discount and offering expenses. If an existing holder supplies it, that holder receives the price less the applicable underwriting discount. Anthropic's cover separates “proceeds, before expenses” to the company from those to selling stockholders, and the underwriting section shows discounts payable by both sides. Every dollar cannot be assigned yet because those fields are blank.^S1

The option is easy to misread. Underwriters may buy additional stock for over-allotments, but Anthropic says those option shares would come from the company, not from the selling stockholders. A full exercise would therefore increase company proceeds and the number of new shares, subject to the final terms. It would not automatically increase the founders' IPO sale amounts.^S1

Anthropic says its net proceeds would support working capital, operating expenses, compute and infrastructure, and hiring and retention. It may also acquire or invest in businesses or technology, although it reports no commitment to a material acquisition. Part of the net proceeds is intended for tax withholding and remittance tied to settlement of certain restricted stock units, or RSUs. That is a company cash use associated with employee equity settlement. It is not a distribution of the founders' secondary-sale proceeds to the workforce.^S1

The S-1 calls one purpose an “orderly distribution of shares for the selling stockholders.” It is a tidy phrase for a real allocation choice: the roadshow can raise growth capital and give named insiders a priced exit in the same transaction. A founder designing an IPO should put the primary and secondary columns side by side before saying how much the company “raised.” The headline gross offering size would combine money with two destinations.

The principal and selling stockholders table names Dario Amodei, Daniela Amodei, Tom Brown, Jack Clark, Jared Kaplan, Sam McCandlish, and Christopher Olah. They are Anthropic's seven co-founders. The five names below “Other Selling Stockholders” are still co-founders; the table heading does not make them unrelated investors. The column for shares being offered is blank for every person, as are their post-offering holdings and voting percentages. The large pre-offering beneficial-ownership figures in adjacent columns are holdings, not proposed IPO sale quantities.^S1

That distinction blocks several tempting but unsupported calculations. We cannot multiply the Amodeis' disclosed holdings by a rumoured price and call the result their IPO cash-out. We cannot say which founder will sell more, what fraction of any founder's stake will be sold, or how much of the public float will come from insiders. We can say that the filing explicitly reserves a seller path for them, and that shares sold by founders through the underwriting agreement are excluded from the lockup on their remaining securities.^S1

The remaining founder holdings face an endpoint at the earlier of the second full trading day after Anthropic releases its third-quarter 2027 results or the close of trading on day 365 after the final prospectus date. A partial release can come sooner: each founder and the other signatories to that founder's lockup may transfer up to 29% of their defined baseline holdings, allocated among them, at the earlier of the second full trading day after first-quarter 2027 results or the day-180 close. The baseline is their aggregate lockup securities on the last day of the month before the prospectus month. The 29% is a cap on a defined pool, not 29% of each founder's present-day beneficial-ownership number, and it is permission to transfer rather than evidence that they will sell.^S1

Selling at the IPO and selling after a lockup are therefore two separate founder decisions. The first happens at the negotiated offer price and is written into the underwriting allocation. The second depends on later dates, market price, legal resale routes, and the holder's choice. A founder can have a yearlong lockup on most holdings and still receive IPO proceeds on day one. Their Class F voting role has a different retained-holding test again. “Founders locked for a year” conceals both the first sale and the separate vote.

Anthropic gives a defined group of non-founder directors, officers, and certain current or former employees and consultants a different schedule. From the start of trading on the first trading day after the final prospectus date, they may transfer up to 10% of the lockup securities they held at the specified baseline date. The baseline is the last day of the month before the prospectus month. The filing says “certain,” so the rule should not be read as a promise that every Anthropic employee can sell 10% of every award on day one.^S1

After public release of Anthropic's full-year 2026 financial results, another 35% of that baseline may transfer from 6:00 a.m. Eastern on the second full trading day. Preliminary or partial earnings do not trigger the clause. The remainder leaves this contractual lockup at the earlier of the second full trading day after first-quarter 2027 results or the trading close on day 180. On the disclosed formula, the early 10% and 35% add to a possible 45% before the endpoint; they do not describe two percentages of a shrinking remainder. The filing does not yet provide share counts for these releases.^S1

The first-day clause has an obvious employee benefit: some holders can reduce concentration without waiting six months. It also lets Anthropic control how much of that cohort can enter public supply at once. “Employee friendly” is not a complete description when the percentage is calculated from a specified past balance, the qualifying employee subset is undefined, and a transfer still needs a usable resale route. The prospectus offers an early door with a turnstile.

RSUs make the distinction concrete. Anthropic expects to spend some IPO proceeds on withholding when certain outstanding RSUs settle. It also says it intends to file Form S-8 registration statements promptly after the offering becomes effective for plan shares, including shares underlying RSUs and options and some previously issued shares. Form S-8 coverage would address a securities-law route, but the filing expressly keeps vesting, affiliate limits, market standoffs, and lockups in play. A person whose RSU has not settled does not own a sale-ready share merely because a lockup percentage has opened.^S1

Rule 701 has its own clock. The S-1 says holders using that resale rule must wait 90 days after the prospectus date, even if their contractual lockup released shares earlier. Another registration or exemption may produce a different result for a particular share. The first-day schedule is therefore the earliest contractual opening for the defined cohort, not a universal legal guarantee of a first-day trade. Treating an early-release table as payroll's promise of cash would be a charming way to discover which document counsel meant you to read next.^S1

Anthropic's schedule is not simply “employees at 180 days, investors at a year.” One group of other stockholders has staged releases inside a 180-day period. Certain stockholders with more than 0.5% of fully diluted shares before the offering have an extended 365-day schedule. The S-1 does not identify every member of either group in its release discussion, and the dollar and share-count columns remain blank. Percentages below refer to each group's defined baseline lockup securities, measured seven days before the final prospectus date, not to the entire company.^S1

These final 14% and 9.1% figures are arithmetic from the S-1's listed tranches, assuming the stated percentages apply to the same baseline. The filing itself leaves the corresponding number of shares blank. If a specified calendar day is not a trading day, the transfer may begin at 6:00 a.m. Eastern on the next trading day; the endpoint clauses have their own trading-day convention. None of these are fixed calendar dates yet because the final prospectus date and earnings release dates are unknown.^S1

The extended schedule reveals the negotiation. A holder in the 365-day group can release small portions long before day 365, but much less than a holder in the ordinary 180-day group at comparable early dates. The founders get an IPO sale path and one 29% partial release; the non-founder employee cohort gets an immediate 10% opening. The percentages express a hierarchy of permitted supply. They do not tell us who will actually place an order or how many shares the market will absorb.

Anthropic's release table is headed “earliest date available for sale in the public market,” but the paragraph above it expressly conditions that availability on the lockup agreements, Rules 144 and 701, and other assumptions. The tabulation assumes no later option exercise or RSU settlement. Affiliates can face Rule 144 volume, manner-of-sale, notice, and public-information requirements; Class N stock has its own conversion and registration path. The company plans Form S-8 filings for employee-plan stock. Those routes matter independently of the release percentages.^S1

There is also discretion. Goldman Sachs and Morgan Stanley, as underwriter representatives, may jointly release locked securities in whole or part, and some discretionary releases can trigger a proportional release for other holders. Anthropic says it may generally waive company market standoffs only with the underwriters' consent. A waiver can change the practical sequence before the printed endpoint; it does not fill in the missing share counts or show a sale occurred.^S1

This is where SpaceX's completed release sequence is useful context. Its unlocks showed that an eligibility number is potential supply, not executed volume. Anthropic has not reached that test. Its S-1 gives a plan for who may approach the market, with no offer price or final quantity. Calling the future unlocked value a cash-out would count shares once as a permission and again as a transaction.

For a founder preparing a similar offering, keep a liquidity schedule beside the cap table. For each holder, record the shares actually offered in the IPO, the security and baseline used for later percentages, each contractual release, the registration or exemption for resale, the vesting and settlement state, withholding, and the company trading policy. Recalculate the company's net primary proceeds separately from the sellers' net secondary proceeds when the red herring gets its numbers. At Anthropic, that update will answer the first question the current filing leaves open: how much of the IPO cheque finances the business, and how much pays existing holders?